A Connectomics Approach to Understanding a Retinal Disease
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Macula Halo Syndrome
Int Ophthalmol (2019) 39:1391–1395 https://doi.org/10.1007/s10792-018-0939-6 CASE REPORT Macula halo syndrome I˙smail Umut Onur . Memhet Fatih As¸ula . Cansu Ekinci . Meral Mert Received: 16 August 2017 / Accepted: 2 May 2018 / Published online: 29 May 2018 Ó Springer Science+Business Media B.V., part of Springer Nature 2018 Abstract granular depositions were detected in the parafoveal Introduction Niemann–Pick disease (NPD) is a retina on both eyes. Optical coherence tomography hereditary lysosomal storage disorder in which muta- (OCT) revealed thin hyperreflective band correspond- tions in the sphingomyelin phosphodiesterase gene ing to depositions located in the parafoveolar inner leads to partial or complete deficiency of the sphin- retina. Microperimeter showed slight depression in gomyelinase enzyme. Niemann–Pick Type B is the retinal sensitivity, which was more pronounced par- intermediate form associated with hep- ticularly on perifovea rather than parafovea. atosplenomegaly, foam cells in the bone marrow, Conclusions Challenge to identify the NPD subtype hyperlipidemia and diffuse pulmonary infiltrates, of this case is associated with phenotypic character- which is generally diagnosed in late adolescence. istics on a wider spectrum that overlap the currently Central nervous system is not affected, and some cases described subtypes. may display macular halo. Case A 45-year-old female seen in ophthalmology Keywords Macula halo Á Niemann–Pick Á clinic for the examination of the eyes. Extraocular Microperimeter motility was normal bilaterally, and the visual acuity was 20/25 for both eyes. Biomicroscopic examination revealed faint corneal haze bilaterally, Circular pale Niemann–Pick disease (NPD) is a hereditary lysoso- mal storage disorder in which mutations in the Electronic supplementary material The online version of sphingomyelin phosphodiesterase gene leads to partial this article (https://doi.org/10.1007/s10792-018-0939-6) con- or complete deficiency of the sphingomyelinase tains supplementary material, which is available to authorized users. -
Emily Y. Chew, M.D
CURRICULUM VITAE Name: Emily Y. Chew Place of Birth: Canton, China Citizenship: United States Marital Status: Married, three children Education 1971-1972 University of British Columbia, Vancouver, B.C., Canada (1st year sciences) 1972-1973 University of Toronto, Canada (2nd year of arts and sciences) 1974-1977 University of Toronto, School of Medicine (6-year program post-high school) 1977-1978 Internship in Internal Medicine, University of Toronto 1978-1981 Residency in Ophthalmology, University of Toronto 1982-1983 Fellowships in Medical Retina & Genetics Johns Hopkins University, Baltimore, (Irene Maumenee, MD, Arnall Patz, MD) University of Nijmegen, Nijmegen, the Netherlands (August Deutman, MD) Brief Chronology of Employment: 1983-1984 Lecturer, University of Toronto, Dept. of Ophthalmology 1985-1986 Assist. Professor, University of Toronto, Dept. of Ophthalmology 1987-1991 Visiting Scientist, Biometry & Epidemiology Program, NEI/NIH 1991-now Medical Officer, Division of Biometry & Epidemiology, NEI/NIH 2000-2017 Deputy Director, Division of Epidemiology and Clinical Applications, NEI. 2008-now Deputy Clinical Director, National Eye Institute 2009-now Chief of Clinical Trials Branch, National Eye Institute 2017-now Director, Division of Epidemiology and Clinical Applications, NEI/NIIH Honors and Other Scientific Recognition: 1981 Research Prize, Ophthalmology, U. of Toronto 1982 E.A. Baker Scholarship for Advanced Training in Ophthalmology 1986 Best Teacher’s Award, Ophthalmology, U. of Toronto 1996 American Academy of Ophthalmology Honors Award 2001 NEI Director’s Award (Achievements in the Age-Related Eye Disease Study) 2001 NEI Director’s Award (Compassion in patient care) 2003 NIH Director’s Award for Excellence in Mentoring 2004 Award of Merit in Retina Research, Schepens Lecture (Retina Society) shared with F.L. -
Copyright and Use of This Thesis This Thesis Must Be Used in Accordance with the Provisions of the Copyright Act 1968
COPYRIGHT AND USE OF THIS THESIS This thesis must be used in accordance with the provisions of the Copyright Act 1968. Reproduction of material protected by copyright may be an infringement of copyright and copyright owners may be entitled to take legal action against persons who infringe their copyright. Section 51 (2) of the Copyright Act permits an authorized officer of a university library or archives to provide a copy (by communication or otherwise) of an unpublished thesis kept in the library or archives, to a person who satisfies the authorized officer that he or she requires the reproduction for the purposes of research or study. The Copyright Act grants the creator of a work a number of moral rights, specifically the right of attribution, the right against false attribution and the right of integrity. You may infringe the author’s moral rights if you: - fail to acknowledge the author of this thesis if you quote sections from the work - attribute this thesis to another author - subject this thesis to derogatory treatment which may prejudice the author’s reputation For further information contact the University’s Copyright Service. sydney.edu.au/copyright Clinical Studies into the Causes of Idiopathic Macular Telangiectasia Type 2: Sleep Apnoea and Macular Telangiectasia: The SAMTel Project Martin Lee Submitted to the Faculty of Medicine in fulfillment of the requirements of the degree Masters of Philosophy (Medicine) Department of Clinical Ophthalmology & Eye Health University of Sydney January 2015 Acknowledgements: To my family, especially parents, Anne and Russell, and siblings Alison and Frances, thank you for your unbridled support and endless encouragement to enable me to continue to pursue my educational interests. -
Macular Telangiectasia Type 2: Quantitative Analysis of a Novel
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery Macular telangiectasia type 2: quantitative analysis of a novel phenotype and implications for the pathobiology of the disease Mali Okada, MBBS, MMed*; Catherine A Egan, FRANZCO*†; Tjebo FC Heeren, MD*‡; Adnan Tufail, MD, FRCOphth*; Marcus Fruttiger, PhD‡; Peter M Maloca, MD*§ * Moorfields Eye Hospital NHS Foundation Trust, London, UK † Department of Ophthalmology, University of Bonn, Bonn, Germany ‡ UCL Institute of Ophthalmology, London, United Kingdom § Department of Ophthalmology, University of Basel, Basel, Switzerland Short Title: Retinal microcystoid spaces in MacTel 2 Funding: Supported by the Lowy Medical Research Institute, Sydney, Australia as part of The Macular Telangiectasia Project (MO, CE). AT receives a proportion of funding from the National Institute for Health Research (NIHR) and Biomedical Research Centre at Moorfields Eye Hospital and the University College London Institute of Ophthalmology. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Financial Disclosures: AT is on the advisory board for Heidelberg engineering (Heidelberg, Germany) and Optovue (Optovue Inc, USA). PM receives fees for lectures from Heidelberg engineering (Heidelberg, Germany) 1 Address for correspondence: Peter M Maloca, MD Moorfields Eye Hospital 162 City Road, London EC1V 2PD London, United Kingdom Tel: +44 20 72533411 Fax: +44 20 72534696 [email protected] Key words Macular telangiectasia type 2; spectral domain optical coherence tomography; volume rendering; microcystoid spaces; cystoid macular oedema; microcystic macular oedema; inner nuclear layer cysts; microcysts; microcavitations Summary Statement Retinal microcystoid spaces are a novel phenotype of Macular Telangiectasia (MacTel) type 2 on optical coherence tomography. -
Embryology, Anatomy, and Physiology of the Afferent Visual Pathway
CHAPTER 1 Embryology, Anatomy, and Physiology of the Afferent Visual Pathway Joseph F. Rizzo III RETINA Physiology Embryology of the Eye and Retina Blood Supply Basic Anatomy and Physiology POSTGENICULATE VISUAL SENSORY PATHWAYS Overview of Retinal Outflow: Parallel Pathways Embryology OPTIC NERVE Anatomy of the Optic Radiations Embryology Blood Supply General Anatomy CORTICAL VISUAL AREAS Optic Nerve Blood Supply Cortical Area V1 Optic Nerve Sheaths Cortical Area V2 Optic Nerve Axons Cortical Areas V3 and V3A OPTIC CHIASM Dorsal and Ventral Visual Streams Embryology Cortical Area V5 Gross Anatomy of the Chiasm and Perichiasmal Region Cortical Area V4 Organization of Nerve Fibers within the Optic Chiasm Area TE Blood Supply Cortical Area V6 OPTIC TRACT OTHER CEREBRAL AREASCONTRIBUTING TO VISUAL LATERAL GENICULATE NUCLEUSPERCEPTION Anatomic and Functional Organization The brain devotes more cells and connections to vision lular, magnocellular, and koniocellular pathways—each of than any other sense or motor function. This chapter presents which contributes to visual processing at the primary visual an overview of the development, anatomy, and physiology cortex. Beyond the primary visual cortex, two streams of of this extremely complex but fascinating system. Of neces- information flow develop: the dorsal stream, primarily for sity, the subject matter is greatly abridged, although special detection of where objects are and for motion perception, attention is given to principles that relate to clinical neuro- and the ventral stream, primarily for detection of what ophthalmology. objects are (including their color, depth, and form). At Light initiates a cascade of cellular responses in the retina every level of the visual system, however, information that begins as a slow, graded response of the photoreceptors among these ‘‘parallel’’ pathways is shared by intercellular, and transforms into a volley of coordinated action potentials thalamic-cortical, and intercortical connections. -
Genetic Disruption of Serine Biosynthesis Is a Key Driver Of
bioRxiv preprint doi: https://doi.org/10.1101/2020.02.04.934356; this version posted February 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genetic Disruption of Serine Biosynthesis is a Key 2 Driver of Macular Telangiectasia Type 2 Etiology and 3 Progression 4 5 RoBerto Bonelli,1,2 Brendan R E Ansell,1,2 Luca Lotta,3 Thomas Scerri,1,2 Traci E Clemons,4 Irene Leung,5 The 6 MacTel Consortium,6 Tunde Peto,7 Alan C Bird,8 Ferenc Sallo,9 Claudia LangenBerg,3 and Melanie Bahlo*1,2. 7 8 9 1 Department of Medical Biology, The University of Melbourne, 3052, Parkville, Victoria, Australia. 10 2 Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, 11 Australia. 12 3 MRC Epidemiology Unit, University of Cambridge, CB2 0SL, Cambridge, UK. 13 4 The EMMES Corporation, Rockville, 20850, Maryland, United States. 14 5 Department of Research and Development, Moorfields Eye Hospital NHS Foundation Trust, EC1V 2PD, London, United 15 Kingdom. 16 6 A list of members and affiliations is provided in Table S8. 17 7 Department of Ophthalmology, Queen’s University, Belfast, BT7 1NN, United Kingdom. 18 8 Inherited Eye Disease, Moorfields Eye Hospital NHS Foundation Trust, EC1V 2PD, London, United Kingdom. 19 9 Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Fondation Asile des aveugles, 20 Switzerland. -
Rotational Three-Dimensional OCTA
www.nature.com/scientificreports OPEN Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization Enrico Borrelli 1, Riccardo Sacconi 1, Gerd Klose2, Luis de Sisternes3, Francesco Bandello1 & Giuseppe Querques 1* This study explored whether rotational three-dimensional (3D) visualization of optical coherence tomography angiography (OCTA) volume data may yield valuable information regarding type 3 macular neovascularization (MNV). In this retrospective, cross-sectional study, we collected data from 15 eyes (13 patients) with treatment-naïve type 3 MNV in their post-nascent stage and age-related macular degeneration (AMD). Subjects were imaged with the SS-OCT system (PLEX Elite 9000, Carl Zeiss Meditec Inc., Dublin, CA, USA). The OCTA volume data were processed with a prototype volume projection removal algorithm and then analyzed using volumetric visualization techniques in order to obtain a 3D visualization of the region occupied by type 3 MNV. The two-dimensional and three-dimensional OCTA images were investigated. Mean ± SD age was 75.1 ± 7.4 years. BCVA was 0.42 ± 0.21 LogMAR in the study eyes. Considering the cohort of analyzed eyes, on rotational 3D OCTA images, a total of 35 neovascular lesions (vs 22 lesions detected on 2D OCTA images) rising from the deep vascular complex and variably spanning the outer retinal layers and eventually reaching the RPE/sub-RPE space were detected. Nine of 35 lesions had a saccular shape, while the remaining cases had a fliform shape. On rotational 3D OCTA images, these lesions were inclined on the three planes, instead of perpendicular to the RPE/Bruch’s membrane. -
In Vivo Foveal Development Using Optical Coherence Tomography
Retina In Vivo Foveal Development Using Optical Coherence Tomography Helena Lee, Ravi Purohit, Aarti Patel, Eleni Papageorgiou, Viral Sheth, Gail Maconachie, Anastasia Pilat, Rebecca J. McLean, Frank A. Proudlock, and Irene Gottlob University of Leicester Ulverscroft Eye Unit, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, United Kingdom Correspondence: Irene Gottlob, PURPOSE. To characterize the time course of normal foveal development in vivo in term infants University of Leicester Ulverscroft and young children using handheld spectral-domain optical coherence tomography (HH- Eye Unit, Robert Kilpatrick Clinical SDOCT). Sciences Building, PO Box 65, Leicester Royal Infirmary, Leicester METHODS. We obtained 534 HH-SDOCT scans from 261 infants, children, and young adults LE2 7LX, UK; with a mean age of 4.9 years (range, 0–27 years). Each retinal layer was manually segmented [email protected]. in ImageJ and correlated with gestational age (GA) and visual acuity (VA). The developmental Submitted: January 26, 2015 trajectories of each retinal layer at the fovea, parafovea, and perifovea were calculated using Accepted: May 3, 2015 fractional polynomial modeling. Citation: Lee H, Purohit R, Patel A, et RESULTS. The central macular thickness (CMT) increases logarithmically between birth and al. In vivo foveal development using 48.6 months GA. The foveal ganglion cell (GCL), inner plexiform, inner nuclear (INL), and optical coherence tomography. Invest outer plexiform layers decrease in thickness exponentially until 18 months GA. Interestingly, Ophthalmol Vis Sci. 2015;56:4537– the parafoveal and perifoveal GCL and INL thicknesses initially decrease until 17 months GA 4545. DOI:10.1167/iovs.15-16542 and then increase in thickness until 65.5 GA. -
(AMD) and a New Metric for Objective Evaluation of the Efficacy of Ocular Nutrition
Nutrients 2012, 4, 1812-1827; doi:10.3390/nu4121812 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Article Retinal Spectral Domain Optical Coherence Tomography in Early Atrophic Age-Related Macular Degeneration (AMD) and a New Metric for Objective Evaluation of the Efficacy of Ocular Nutrition Stuart Richer 1,2,*, Jane Cho 1,2, William Stiles 1, Marc Levin 1, James S. Wrobel 3, Michael Sinai 4 and Carla Thomas 1 1 Eye Clinic, James A Lovell Federal Health Care Center, North Chicago, IL 60064, USA; E-Mails: [email protected] (J.C.); [email protected] (W.S.); [email protected] (M.L.); [email protected] (C.T.) 2 Family & Preventive Medicine, RFUMS Chicago Medical School, North Chicago, IL 60064, USA 3 Internal Medicine, Podiatry Services, University of Michigan, Ann Arbor, MI 48105, USA; E-Mail: [email protected] 4 Optovue Inc., Fremont, CA 94538, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-224-610-7145. Received: 11 October 2012; in revised form: 12 November 2012 / Accepted: 14 November 2012 / Published: 27 November 2012 Abstract: Purpose: A challenge in ocular preventive medicine is identification of patients with early pathological retinal damage that might benefit from nutritional intervention. The purpose of this study is to evaluate retinal thinning (RT) in early atrophic age-related macular degeneration (AMD) against visual function data from the Zeaxanthin and Visual Function (ZVF) randomized double masked placebo controlled clinical trial (FDA IND #78973). Methods: Retrospective, observational case series of medical center veterans with minimal visible AMD retinopathy (AREDS Report #18 simplified grading 1.4/4.0 bilateral retinopathy). -
Pediatric Retina
Pediatric Retina Bearbeitet von James D. Reynolds, Scott E. Olitsky 1st Edition. 2010. Buch. viii, 462 S. Hardcover ISBN 978 3 642 12040 4 Format (B x L): 19,3 x 26 cm Gewicht: 1190 g Weitere Fachgebiete > Medizin > Klinische und Innere Medizin > Augenheilkunde, Optometrie Zu Inhaltsverzeichnis schnell und portofrei erhältlich bei Die Online-Fachbuchhandlung beck-shop.de ist spezialisiert auf Fachbücher, insbesondere Recht, Steuern und Wirtschaft. Im Sortiment finden Sie alle Medien (Bücher, Zeitschriften, CDs, eBooks, etc.) aller Verlage. Ergänzt wird das Programm durch Services wie Neuerscheinungsdienst oder Zusammenstellungen von Büchern zu Sonderpreisen. Der Shop führt mehr als 8 Millionen Produkte. Anatomy and Physiology of the Retina 2 Göran Darius Hildebrand and Alistair R. Fielder 2.1 Introduction optic disc and is about 1.5 mm, or one disc size, in diameter [7]. The center of the macula lies just below the horizontal meridian [8], a relationship that is used The retina remains the best studied part of the human to study rotation during incyclo and excyclotorsion. brain. Embryologically part of the central nervous sys- The presence of xanthophyll, a yellow carotenoid pig- tem [1–5], but readily accessible to examination, it can ment, gives the region its name – the macula lutea. be investigated with relative ease by both scientists and The most central part of the macula, the fovea (ana- clinicians. Moreover, an estimated 80% of all sensory tomic foveola), is formed by a central, circa 0.35 mm- information in humans is thought to be of retinal origin wide depression and represents the retinal region of [6], indicating the importance of retinal function for the greatest visual acuity [9]. -
Decrease in Inner Retinal Thickness at Para- and Perifoveal Areas Before Vascular Retinopathy in Patients with Metabolic Risk Factors
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Taiwan Journal of Ophthalmology 3 (2013) 108e115 Contents lists available at SciVerse ScienceDirect Taiwan Journal of Ophthalmology journal homepage: www.e-tjo.com Original article Decrease in inner retinal thickness at para- and perifoveal areas before vascular retinopathy in patients with metabolic risk factors Ko-Jo Lin a, Mei-Xue Loi a, Shao-Yu Lei a, Chao-Chun Shiau a, Chien-Liang Wu a,b,*, Jennifer Hui-Chun Ho a,b,c,* a Department of Ophthalmology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan b Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan c Center for Stem Cell Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan article info abstract Article history: Background: Hypertension, dyslipidemia, and hyperglycemia are major risk factors for vascular reti- Received 1 April 2013 nopathy. The relationship between retinal thickness at the macular area and metabolic risk factors, as Received in revised form well as visual impairment, in elderly patients before developing vascular occlusion needs to be 13 May 2013 investigated. Accepted 22 May 2013 Methods: In this prospective, case-control study, patients >60 years old, without objective visual Available online 12 July 2013 threatened ocular diseases or systemic abnormalities, except for hypertension, dyslipidemia or/and hy- perglycemia, were included for measurement of retinal thickness at the macular area by optical coher- Keywords: inner retina ence tomography (OCT). macular thickness Results: Fifty-four patients were analyzed; 11 patients had no metabolic risk factors, 16 had one, 17 had metabolic risk factors two, and 10 had three. -
Improving Anti-VEGF Drugs in the Vitreous by Eda Isil Altiok A
Improving Anti-VEGF Drugs in the Vitreous By Eda Isil Altiok A dissertation submitted in partial satisfaction of the Requirement for the degree of Joint Doctor of Philosophy with UC San Francisco In Bioengineering In the graduate division Of the University of California, Berkeley Committee in charge: Professor Kevin E. Healy, Chair Professor David Schaffer Professor Tejal Desai Professor Anthony Adams Fall 2015 Improving Anti-VEGF Drugs in the Vitreous © 2015 by Eda Isil Altiok University of California, Berkeley Abstract Improving Anti-VEGF Drugs in the Vitreous By Eda Isil Altiok Doctor of Philosophy in Bioengineering University of California, Berkeley Professor Kevin Healy, Chair The work described in this dissertation present a novel technique utilizing multivalent hyaluronic acid bioconjugates with an anti-VEGF protein for improving the action of drugs in the vitreous. This technology, which has shown efficacy both in vitro and in vivo has the potential to enhance the bioactivity of drugs used for treating patients with diseases including diabetic retinopathy, wet AMD and other neovascular diseases of the retina. Chapter 2 described our initial efforts in creating multivalent conjugates of the anti-VEGF protein, sFlt. Before beginning in vivo studies, we wanted to determine what parameters would maximize the bioactivity of mvsFlt. We investigated the use of several HyA molecular weights and valencies of sFlt molecules to HyA chains. The characterization and in vitro experiments were carried out with 6 mvsFlt conjugates of 300 kDa, 650 kDa and 1 MDa molecular weights with feed ratios of 10 sFlt per 1 HyA chain (termed low conjugation ratio (LCR)) and 30 sFlt per 1 HyA chain (termed high conjugation ratio (HCR)).